Product image of Mupider (Mupirocin Calcium) supplied by GNH India

Mupider

Active Ingredient:
Mupirocin Calcium
Origin:
EU

Mupider (Mupirocin Calcium)

Mupirocin calcium, the active ingredient in Mupider, is a mupirocin (monoxycarbolic acid antibiotic) presented as a topical preparation for cutaneous use. It treats impetigo and secondary bacterial skin infections in patients of all ages when applied to the affected area.
GNH India supplies Mupider as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Kleva Pharmaceuticals

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mupider is a topical antibacterial indicated for skin conditions caused by susceptible bacteria.

  • Impetigo: reduces lesion size and accelerates healing of superficial bacterial infection.
  • Secondary bacterial skin infections: controls bacterial proliferation in wounds, burns or dermatitis.
  • Superficial skin infections: provides localized antibacterial activity to prevent spread of infection.

How It Works

  • Mupirocin calcium inhibits bacterial isoleucyl‑tRNA synthetase, an enzyme essential for protein synthesis. By blocking the attachment of isoleucine to its tRNA, the drug prevents the formation of functional bacterial proteins, leading to growth arrest and bacterial cell death in susceptible Gram‑positive organisms.

Side Effects

Mupider may cause local and systemic adverse reactions.

Common Side Effects

  • Itching: mild to moderate pruritus at the application site.
  • Burning sensation: transient warmth or stinging after application.
  • Redness: erythema localized to treated area.
  • Pain: discomfort or tenderness at the site.
  • Dry skin: occasional flaking or scaling.
  • Rash: mild maculopapular eruption.

Serious or Rare Side Effects

  • Allergic reaction: angioedema or anaphylaxis requiring immediate medical attention.
  • Contact dermatitis: severe skin inflammation with vesiculation.
  • Systemic infection: rare systemic absorption leading to infection elsewhere.
  • Stevens‑Johnson syndrome: rare severe mucocutaneous reaction.
  • Toxic epidermal necrolysis: life‑threatening skin detachment.
  • Hepatic dysfunction: very rare elevation of liver enzymes.

Precautions & Warnings

Before using Mupider, consider the following safety measures.

  • Hypersensitivity: avoid if known allergy to mupirocin or formulation components.
  • Large‑area application: limit use to small affected areas; avoid extensive body surface coverage.
  • Open wounds: do not apply to deep or necrotic tissue without medical supervision.
  • Pediatric use: use only under pediatrician guidance for children.
  • Pregnancy and lactation: consult healthcare professional before use.
  • Storage: Store at room temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Mupider has limited systemic interactions, but caution is advised with certain co‑administered agents.

Major Interactions (Avoid)

  • Concurrent topical antibiotics: may increase risk of local irritation or allergic reactions.
  • Occlusive dressings: can enhance systemic absorption, raising potential toxicity.

Moderate Interactions (Monitor Closely)

  • Systemic antibiotics: may alter skin flora and affect mupirocin efficacy.
  • Immunosuppressants: increased susceptibility to secondary infections.
  • Antifungal creams: possible reduced effectiveness of either agent when used together on the same site.

Frequently Asked Questions

Mupider is a topical antibacterial indicated for impetigo and other secondary bacterial skin infections such as infected cuts, abrasions, or dermatitis. It works by eliminating susceptible Gram‑positive bacteria on the skin, helping to reduce lesion size and promote healing.

Mupirocin calcium blocks the bacterial enzyme isoleucyl‑tRNA synthetase, which is required for attaching the amino acid isoleucine to its tRNA during protein synthesis. This inhibition halts bacterial protein production, leading to growth arrest and death of susceptible organisms.

The specific dose and frequency of Mupider are determined by the prescribing healthcare professional based on the infection type, severity, patient age, and body surface area involved. Patients should follow the prescriber’s instructions and the product label.

Safety data for mupirocin calcium in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any unknown risks before prescribing Mupider to pregnant or nursing individuals. Consultation with a medical professional is essential.

To request Mupider, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and import documentation.

Mupider (mupirocin calcium) offers a broad spectrum against Staphylococcus aureus and Streptococcus pyogenes, often with lower resistance rates compared with agents like fusidic acid or bacitracin. Its unique mechanism targeting isoleucyl‑tRNA synthetase provides effective treatment for impetigo, whereas some alternatives may be less potent against certain resistant strains.

Mupider should be stored at room temperature below 25 °C, in its original container, protected from moisture and direct sunlight. Do not freeze the product, and keep it out of reach of children to maintain stability and potency.

Mupider is applied topically to the affected skin area. The prescribed amount is spread thinly over the lesion, usually two to three times daily, and gently rubbed in. Hands should be washed before and after application, and the treated area should be covered only if directed by a clinician.

Serious risks, though rare, include severe allergic reactions such as angioedema, anaphylaxis, and life‑threatening skin conditions like Stevens‑Johnson syndrome or toxic epidermal necrolysis. Patients should seek immediate medical attention if they experience widespread rash, blistering, swelling, or difficulty breathing.

Mupider should not be used by individuals with a known hypersensitivity to mupirocin calcium or any excipients in the formulation. It is also contraindicated on large body surface areas, deep or necrotic wounds without medical supervision, and in patients where a safer alternative is available.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mupirocin Calcium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT